Skip Navigation


European Heart Journal Advance Access originally published online on March 24, 2005
European Heart Journal 2005 26(11):1054-1055; doi:10.1093/eurheartj/ehi246
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/11/1054    most recent
ehi246v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bax, J. J.
Right arrow Articles by Schalij, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bax, J. J.
Right arrow Articles by Schalij, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

How to predict response to cardiac resynchronization therapy?

Jeroen J. Bax* and Martin J. Schalij

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands

* Corresponding author. Tel: +31 71 5262020; fax: +31 71 5266809. E-mail address: jbax@knoware.nl

This editorial refers to ‘Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure’ by G. Lecoq et al.,{dagger} on page 1094

The first 10% of the full text of this article appears below.

Cardiac resynchronization therapy (CRT) is considered a major breakthrough in the treatment of patients with end-stage heart failure.1 Initial studies demonstrated an acute improvement in haemodynamics immediately after CRT, whereas a large number of studies with mid-term follow-up (6 months to 1 year) demonstrated an improvement in heart failure symptoms, quality-of-life score, exercise capacity, and left ventricular (LV) systolic performance.1 In addition, Bradley et al.2 demonstrated in a meta-analysis, a reduced risk for heart failure death at mid-term (6 months) follow-up in patients undergoing CRT when compared with optimized medical therapy. Moreover, studies with long-term follow-up now demonstrate sustained improvement over . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure
Guillaume Lecoq, Christophe Leclercq, Emmanuelle Leray, Christophe Crocq, Christine Alonso, Christian de Place, Philippe Mabo, and Claude Daubert
EHJ 2005 26: 1094-1100. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
J. G.F. Cleland, A. T. Abdellah, O. Khaleva, A. P. Coletta, and A. L. Clark
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure
Eur J Heart Fail, October 1, 2007; 9(10): 1070 - 1073.
[Abstract] [Full Text] [PDF]